Guggenheim initiated coverage of Q32 Bio with a Buy rating and $100 price target.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on QTTB:
- Disney and HP upgraded: Wall Street’s top analyst calls
- Q32 Bio initiated with an Outperform at Leerink
- Q32 Bio Inc. Faces New Financial Hurdles as Increased Regulatory Compliance Looms
- Q32 Bio reports Q1 EPS ($6.33), consensus ($2.32)
- Q32 Bio Reports First Quarter 2024 Financial Results and Provides Corporate Update
Questions or Comments about the article? Write to editor@tipranks.com